Press release
Opioid-Induced Constipation Market Size And Outlook By 2027| Takeda Pharmaceuticals, Bayer, Sanofi
Los Angeles, United State, – The report titled Opioid-Induced Constipation Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Opioid-Induced Constipation market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Opioid-Induced Constipation market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Opioid-Induced Constipation market is carefully analyzed and researched about by the market analysts.
Request Sample Report and Full Report TOC:
https://www.qyresearch.com/sample-form/form/2770658/global-opioid-induced-constipation-sales-market
The Essential Content Covered in the Global Opioid-Induced Constipation Market Report :
* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size
Global Opioid-Induced Constipation Market is estimated to reach million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of QY Research the Opioid-Induced Constipation market has witnessed unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.
Top Players of Opioid-Induced Constipation Market are Studied: Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health), AstraZeneca, Progenics Pharmaceuticals, Purdue Pharm, Nektar Therapeutics, Daiichi Sankyo, Prestige, GSK, Shionogi
The report provides a 6-year forecast (2020-2026) assessed based on how the Opioid-Induced Constipation market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.
Segmentation by Type: , Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Others
Segmentation by Application: Hospital, Pharmacy, Other
Reasons to Buy this Report:
Industry Size & Forecast: Estimations on the global Opioid-Induced Constipation industry size on the basis of value and volume are provided in this part of the report
Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming Opioid-Induced Constipation trends
Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end users, taking into account their CAGR, share, and size
Future Prospects: Current Opioid-Induced Constipation developments and future opportunities estimated to emerge in the Opioid-Induced Constipation industry are looked into in this portion of the study
Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
Get Full Customize report or for any Special Discount visit@
https://www.qyresearch.com/customize-request/form/2770658/global-opioid-induced-constipation-sales-market
TOC
1 Opioid-Induced Constipation Market Overview
1.1 Opioid-Induced Constipation Product Scope
1.2 Opioid-Induced Constipation Segment by Type
1.2.1 Global Opioid-Induced Constipation Sales by Type (2016 & 2021 & 2027)
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Opioid-Induced Constipation Segment by Application
1.3.1 Global Opioid-Induced Constipation Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Opioid-Induced Constipation Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioid-Induced Constipation Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioid-Induced Constipation Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioid-Induced Constipation Price Trends (2016-2027) 2 Opioid-Induced Constipation Estimates and Forecasts by Region
2.1 Global Opioid-Induced Constipation Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioid-Induced Constipation Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioid-Induced Constipation Sales Market Share by Region (2016-2021)
2.2.2 Global Opioid-Induced Constipation Revenue Market Share by Region (2016-2021)
2.3 Global Opioid-Induced Constipation Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioid-Induced Constipation Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioid-Induced Constipation Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.2 Europe Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.3 China Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.4 Japan Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioid-Induced Constipation Estimates and Projections (2016-2027)
2.4.6 India Opioid-Induced Constipation Estimates and Projections (2016-2027) 3 Global Opioid-Induced Constipation Competition Landscape by Players
3.1 Global Top Opioid-Induced Constipation Players by Sales (2016-2021)
3.2 Global Top Opioid-Induced Constipation Players by Revenue (2016-2021)
3.3 Global Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid-Induced Constipation as of 2020)
3.4 Global Opioid-Induced Constipation Average Price by Company (2016-2021)
3.5 Manufacturers Opioid-Induced Constipation Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Opioid-Induced Constipation Market Size by Type
4.1 Global Opioid-Induced Constipation Historic Market Review by Type (2016-2021)
4.1.1 Global Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
4.1.2 Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioid-Induced Constipation Price by Type (2016-2021)
4.2 Global Opioid-Induced Constipation Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioid-Induced Constipation Sales Forecast by Type (2022-2027)
4.2.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioid-Induced Constipation Price Forecast by Type (2022-2027) 5 Global Opioid-Induced Constipation Market Size by Application
5.1 Global Opioid-Induced Constipation Historic Market Review by Application (2016-2021)
5.1.1 Global Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
5.1.2 Global Opioid-Induced Constipation Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioid-Induced Constipation Price by Application (2016-2021)
5.2 Global Opioid-Induced Constipation Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioid-Induced Constipation Sales Forecast by Application (2022-2027)
5.2.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioid-Induced Constipation Price Forecast by Application (2022-2027) 6 North America Opioid-Induced Constipation Market Facts & Figures
6.1 North America Opioid-Induced Constipation Sales by Company
6.1.1 North America Opioid-Induced Constipation Sales by Company (2016-2021)
6.1.2 North America Opioid-Induced Constipation Revenue by Company (2016-2021)
6.2 North America Opioid-Induced Constipation Sales Breakdown by Type
6.2.1 North America Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
6.3 North America Opioid-Induced Constipation Sales Breakdown by Application
6.3.1 North America Opioid-Induced Constipation Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioid-Induced Constipation Sales Breakdown by Application (2022-2027) 7 Europe Opioid-Induced Constipation Market Facts & Figures
7.1 Europe Opioid-Induced Constipation Sales by Company
7.1.1 Europe Opioid-Induced Constipation Sales by Company (2016-2021)
7.1.2 Europe Opioid-Induced Constipation Revenue by Company (2016-2021)
7.2 Europe Opioid-Induced Constipation Sales Breakdown by Type
7.2.1 Europe Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
7.3 Europe Opioid-Induced Constipation Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027) 8 China Opioid-Induced Constipation Market Facts & Figures
8.1 China Opioid-Induced Constipation Sales by Company
8.1.1 China Opioid-Induced Constipation Sales by Company (2016-2021)
8.1.2 China Opioid-Induced Constipation Revenue by Company (2016-2021)
8.2 China Opioid-Induced Constipation Sales Breakdown by Type
8.2.1 China Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
8.2.2 China Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
8.3 China Opioid-Induced Constipation Sales Breakdown by Application
8.3.1 China 157 Sales Breakdown by Application (2016-2021)
8.3.2 China 157 Sales Breakdown by Application (2022-2027) 9 Japan Opioid-Induced Constipation Market Facts & Figures
9.1 Japan Opioid-Induced Constipation Sales by Company
9.1.1 Japan Opioid-Induced Constipation Sales by Company (2016-2021)
9.1.2 Japan Opioid-Induced Constipation Revenue by Company (2016-2021)
9.2 Japan Opioid-Induced Constipation Sales Breakdown by Type
9.2.1 Japan Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
9.3 Japan Opioid-Induced Constipation Sales Breakdown by Application
9.3.1 Japan June Sales Breakdown by Application (2016-2021)
9.3.2 Japan June Sales Breakdown by Application (2022-2027) 10 Southeast Asia Opioid-Induced Constipation Market Facts & Figures
10.1 Southeast Asia Opioid-Induced Constipation Sales by Company
10.1.1 Southeast Asia Opioid-Induced Constipation Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioid-Induced Constipation Revenue by Company (2016-2021)
10.2 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type
10.2.1 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioid-Induced Constipation Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Opioid-Induced Constipation Market Facts & Figures
11.1 India Opioid-Induced Constipation Sales by Company
11.1.1 India Opioid-Induced Constipation Sales by Company (2016-2021)
11.1.2 India Opioid-Induced Constipation Revenue by Company (2016-2021)
11.2 India Opioid-Induced Constipation Sales Breakdown by Type
11.2.1 India Opioid-Induced Constipation Sales Breakdown by Type (2016-2021)
11.2.2 India Opioid-Induced Constipation Sales Breakdown by Type (2022-2027)
11.3 India Opioid-Induced Constipation Sales Breakdown by Application
11.3.1 India Opioid-Induced Constipation Sales Breakdown by Application (2016-2021)
11.3.2 India Opioid-Induced Constipation Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Opioid-Induced Constipation Business
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Corporation Information
12.1.2 Takeda Pharmaceuticals Business Overview
12.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Products Offered
12.1.5 Takeda Pharmaceuticals Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Opioid-Induced Constipation Products Offered
12.2.5 Bayer Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Opioid-Induced Constipation Products Offered
12.3.5 Sanofi Recent Development
12.4 Mallinckrodt
12.4.1 Mallinckrodt Corporation Information
12.4.2 Mallinckrodt Business Overview
12.4.3 Mallinckrodt Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mallinckrodt Opioid-Induced Constipation Products Offered
12.4.5 Mallinckrodt Recent Development
12.5 Salix (Bausch Health)
12.5.1 Salix (Bausch Health) Corporation Information
12.5.2 Salix (Bausch Health) Business Overview
12.5.3 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Salix (Bausch Health) Opioid-Induced Constipation Products Offered
12.5.5 Salix (Bausch Health) Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Opioid-Induced Constipation Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Progenics Pharmaceuticals
12.7.1 Progenics Pharmaceuticals Corporation Information
12.7.2 Progenics Pharmaceuticals Business Overview
12.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Products Offered
12.7.5 Progenics Pharmaceuticals Recent Development
12.8 Purdue Pharm
12.8.1 Purdue Pharm Corporation Information
12.8.2 Purdue Pharm Business Overview
12.8.3 Purdue Pharm Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Purdue Pharm Opioid-Induced Constipation Products Offered
12.8.5 Purdue Pharm Recent Development
12.9 Nektar Therapeutics
12.9.1 Nektar Therapeutics Corporation Information
12.9.2 Nektar Therapeutics Business Overview
12.9.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Nektar Therapeutics Opioid-Induced Constipation Products Offered
12.9.5 Nektar Therapeutics Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Corporation Information
12.10.2 Daiichi Sankyo Business Overview
12.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Daiichi Sankyo Opioid-Induced Constipation Products Offered
12.10.5 Daiichi Sankyo Recent Development
12.11 Prestige
12.11.1 Prestige Corporation Information
12.11.2 Prestige Business Overview
12.11.3 Prestige Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Prestige Opioid-Induced Constipation Products Offered
12.11.5 Prestige Recent Development
12.12 GSK
12.12.1 GSK Corporation Information
12.12.2 GSK Business Overview
12.12.3 GSK Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.12.4 GSK Opioid-Induced Constipation Products Offered
12.12.5 GSK Recent Development
12.13 Shionogi
12.13.1 Shionogi Corporation Information
12.13.2 Shionogi Business Overview
12.13.3 Shionogi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shionogi Opioid-Induced Constipation Products Offered
12.13.5 Shionogi Recent Development 13 Opioid-Induced Constipation Manufacturing Cost Analysis
13.1 Opioid-Induced Constipation Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioid-Induced Constipation
13.4 Opioid-Induced Constipation Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioid-Induced Constipation Distributors List
14.3 Opioid-Induced Constipation Customers 15 Market Dynamics
15.1 Opioid-Induced Constipation Market Trends
15.2 Opioid-Induced Constipation Drivers
15.3 Opioid-Induced Constipation Market Challenges
15.4 Opioid-Induced Constipation Market Restraints 16 Research Findings and Conclusion 17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid-Induced Constipation Market Size And Outlook By 2027| Takeda Pharmaceuticals, Bayer, Sanofi here
News-ID: 2337382 • Views: …
More Releases from QY Research, Inc
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur.
The global…
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission.
The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach…
More Releases for Constipation
Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period?
The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing…
Key Trends Shaping the Future Constipation Laxative Market From 2025-2034: Innov …
How Are the key drivers contributing to the expansion of the constipation laxative market?
The rising prevalence of constipation is expected to boost the growth of the constipation laxative market. Constipation, characterized by infrequent or difficult bowel movements, is becoming more common due to changes in diet, sedentary lifestyles, inadequate fluid intake, and medical conditions. Constipation laxatives help relieve this condition by stimulating bowel movements or softening stools. A 2024 survey…
Leading Element Driving Change in the Constipation Laxative Market in 2025: Incr …
What Is the Estimated Market Size and Growth Rate for the Constipation Laxative Market?
The market for constipation laxatives has seen substantial expansion in the past few years. It is projected to further expand from $7 billion in 2024 to $7.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include an increase in the elderly population, sedentary lifestyles,…
[Latest] Constipation Treatment Market : An Overview
The ""Constipation Treatment Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Constipation Treatment Market, 2024-2031
Verified Market Research's most recent report, ""Constipation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,"" provides an in-depth…
How to Improve Constipation - Cassia Fistula Extract
Cassia Fistula Extract is a natural plant ingredient extracted from the friut of the Cassia Fistula tree and is widely used in traditional Chinese medicine and modern medicine.
Here are some common applications of Cassia Fistula Extract [https://www.ie-extract.com/cassia-fistula-extract-cassia-fistula-extract-treatment-of-constipation-product/]:
Promotes bowel movement and relieves constipation: Cassia Fistula Extract is believed to promote bowel movement and relieve constipation. Research shows that its active ingredients can stimulate intestinal motility, increase bowel movement frequency, and improve…
Opioid Induced Constipation Treatment Market
Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to drugs that are derivatives of opium, including morphine. Constipation means bowel actions that are sporadic or hard to go by. The fecal matter is often dry and hard. Some of…
